T Ohnoshi

880 total citations
92 papers, 721 citations indexed

About

T Ohnoshi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, T Ohnoshi has authored 92 papers receiving a total of 721 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Oncology, 35 papers in Pulmonary and Respiratory Medicine and 25 papers in Epidemiology. Recurrent topics in T Ohnoshi's work include Lung Cancer Research Studies (25 papers), Lung Cancer Treatments and Mutations (18 papers) and Neuroendocrine Tumor Research Advances (17 papers). T Ohnoshi is often cited by papers focused on Lung Cancer Research Studies (25 papers), Lung Cancer Treatments and Mutations (18 papers) and Neuroendocrine Tumor Research Advances (17 papers). T Ohnoshi collaborates with scholars based in Japan, United States and Greece. T Ohnoshi's co-authors include Hiroshi Ueoka, Katsuyuki Kiura, Ikuro Kimura, James F. Holland, Kevin J. Scanlon, Barton A. Kamen, Takao Ohnuma, I Kimura, Nagio Takigawa and Takuo Shibayama and has published in prestigious journals such as Blood, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

T Ohnoshi

82 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T Ohnoshi Japan 14 308 200 192 159 111 92 721
J. C. O’Keane Ireland 15 248 0.8× 157 0.8× 79 0.4× 75 0.5× 144 1.3× 28 737
Nanette McAtee United States 12 377 1.2× 128 0.6× 241 1.3× 169 1.1× 32 0.3× 16 1.0k
Colette Chapuis‐Cellier France 15 157 0.5× 111 0.6× 150 0.8× 41 0.3× 98 0.9× 40 604
Horacio Oliva Spain 13 148 0.5× 246 1.2× 152 0.8× 106 0.7× 247 2.2× 17 760
Peter Moosmann Switzerland 15 264 0.9× 77 0.4× 392 2.0× 237 1.5× 35 0.3× 23 938
S. D. Perova Russia 5 126 0.4× 146 0.7× 227 1.2× 76 0.5× 121 1.1× 8 728
Deborah Belchis United States 20 195 0.6× 223 1.1× 270 1.4× 341 2.1× 35 0.3× 44 1.1k
Joseph Shuster Canada 15 105 0.3× 87 0.4× 155 0.8× 80 0.5× 50 0.5× 34 590
Yukio Osada Japan 23 225 0.7× 115 0.6× 366 1.9× 293 1.8× 100 0.9× 60 1.3k
Charles E. Welander United States 16 192 0.6× 81 0.4× 184 1.0× 77 0.5× 19 0.2× 36 861

Countries citing papers authored by T Ohnoshi

Since Specialization
Citations

This map shows the geographic impact of T Ohnoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T Ohnoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T Ohnoshi more than expected).

Fields of papers citing papers by T Ohnoshi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T Ohnoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T Ohnoshi. The network helps show where T Ohnoshi may publish in the future.

Co-authorship network of co-authors of T Ohnoshi

This figure shows the co-authorship network connecting the top 25 collaborators of T Ohnoshi. A scholar is included among the top collaborators of T Ohnoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T Ohnoshi. T Ohnoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moritaka, Tomonori, Katsuyuki Kiura, Hiroshi Ueoka, et al.. (1998). Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.. PubMed. 18(2A). 927–33. 20 indexed citations
2.
Ueoka, Hiroshi, Masahiro Tabata, Takuo Shibayama, et al.. (1995). [Gingival metastasis of large-cell lung cancer that produced G-CSF].. PubMed. 33(11). 1283–7. 3 indexed citations
3.
Kawashima, Kunihiro, et al.. (1994). Epstein‐Barr Virus‐associated Post‐transplant Non‐Hodgkin's Lymphoma: Establishment and Characterization of a New Cell Line. Japanese Journal of Cancer Research. 85(11). 1080–1086. 2 indexed citations
4.
Kiura, Katsuyuki, T Ohnoshi, Masahiro Tabata, Takuo Shibayama, & Ikuro Kimura. (1993). Establishment of an adriamycin-resistant subline of human small cell lung cancer showing multifactorial mechanisms of resistance.. Okayama University Scientific Achievement Repository (Okayama University). 47(3). 191–7. 10 indexed citations
5.
Takigawa, Nagio, T Ohnoshi, Hiroshi Ueoka, Katsuyuki Kiura, & I Kimura. (1992). Establishment and characterization of an etoposide-resistant human small cell lung cancer cell line.. PubMed. 46(3). 203–12. 23 indexed citations
6.
Kataoka, Mikio, Shinya Tada, Kiyoshi Takahashi, et al.. (1992). Successful treatment with ciclosporin A of a patient with cytophagic histiocytic panniculitis presenting with pulmonary infiltrates.. Japanese Journal of Clinical Immunology. 15(3). 317–325. 2 indexed citations
7.
Ohnoshi, T, Shuichi Hiraki, Masashi Fujii, et al.. (1991). Phase II study of ifosfamide, cisplatin, and vindesine combination in advanced non-small cell lung cancer.. PubMed. 45(5). 357–61. 5 indexed citations
8.
Segawa, Yoshihiko, T Ohnoshi, Hiroshi Ueoka, et al.. (1991). [Double cancer in small cell lung cancer patients treated with intensive chemotherapy with or without radiation therapy].. PubMed. 29(11). 1432–8. 2 indexed citations
9.
Kamei, Haruhito, et al.. (1990). Four cases of lung cancer with metastasis to the hand.. Haigan. 30(6). 935–940.
10.
Ueoka, Hiroshi, T Ohnoshi, Takeyuki Numata, et al.. (1990). A patient with squamous cell carcinoma of the lung selectively developing multiple metastases in skeletal muscle.. Haigan. 30(7). 1055–1060. 7 indexed citations
11.
Ueoka, Hiroshi, Katsuyuki Kiura, Akihiro Bessho, et al.. (1990). Chemotherapy in small cell lung cancer. Lung Cancer. 6(5-6). 207–207. 1 indexed citations
12.
Ueoka, Hiroshi, T Ohnoshi, Shunkichi Hiraki, et al.. (1989). [Pilot phase II study of hybrid chemotherapy of CAV-PVP in small cell lung cancer (SCLC)].. PubMed. 16(6). 2251–5. 1 indexed citations
13.
Mori, Yoshihiro, et al.. (1989). [Interleukin-2 production and receptor expression of alveolar lymphocytes stimulated by Propionibacterium acnes in sarcoidosis].. PubMed. 27(1). 42–50. 8 indexed citations
14.
Shimoyama, M, T. Abe, K Minato, et al.. (1987). Chromosome aberrations and clinical features of adult T cell leukemia- lymphoma not associated with human T cell leukemia virus type I. Blood. 69(4). 984–989. 26 indexed citations
15.
Kimura, Ikuo, et al.. (1987). [Establishment of adriamycin-resistant human small-cell lung cancer cells in culture: analysis of the mechanism of resistance and cross-resistance].. PubMed. 14(3 Pt 2). 830–6. 1 indexed citations
16.
Hiraki, Shuichi, et al.. (1986). Anticancer drug sensitivity by human tumor clonogenic assay.. Okayama University Scientific Achievement Repository (Okayama University). 40(5). 265–9. 3 indexed citations
17.
Ohnoshi, T, T Ohnuma, J. Beránek, & J F Holland. (1985). Combined Cytotoxicity Effect of Hyperthermia and Anthracycline Antibiotics on Human Tumor Cells<xref ref-type="fn" rid="FN2">2</xref>. JNCI Journal of the National Cancer Institute. 74(2). 275–81. 16 indexed citations
18.
Ogawa, Masako, Ota K, Atsushi Oyama, et al.. (1983). [Phase I study of an oral administration of VP 16-213].. PubMed. 10(11). 2403–7. 1 indexed citations
19.
Ohnoshi, T, Shunkichi Hiraki, Yasunari Nakata, et al.. (1983). Combination chemotherapy for small cell carcinoma of the lung: evaluation of four-drug combination of cyclophosphamide, vincristine, methotrexate, and procarbazine.. PubMed. 37(2). 147–53. 2 indexed citations
20.
Kimura, I, T Ohnoshi, Masafumi Fujii, et al.. (1978). An evaluation of effects of chemotherapy and radiotherapy in small cell carcinoma of the lung. Haigan. 18(3). 231–240.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. C. O’Keane Breakdown of academic impact, for papers by Nanette McAtee Breakdown of academic impact, for papers by Colette Chapuis‐Cellier Breakdown of academic impact, for papers by Horacio Oliva Breakdown of academic impact, for papers by Peter Moosmann Breakdown of academic impact, for papers by S. D. Perova Breakdown of academic impact, for papers by Deborah Belchis Breakdown of academic impact, for papers by Joseph Shuster Breakdown of academic impact, for papers by Yukio Osada Breakdown of academic impact, for papers by Charles E. Welander
Rankless by CCL
2026